MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s00262-025-04252-4

Медицинская библиотека · Cancer immunology, immunotherapy : CII · 2025

Gut microbial metabolite butyrate boosts p53-expressing telomerase-specific oncolytic adenovirus efficacy by enhancing infectivity and activating MHC-I/cGAS-STING.

Sakamoto Masaki, Kuroda Shinji, Katayama Tetsuya, Mikane Yu, Hanzawa Shunya, Kadowaki Daisuke, Yoshida Yusuke, Hamada Yuki, Sugimoto Ryoma, Yagi Chiaki, Hashimoto Masashi, Kanaya Nobuhiko, Kakiuchi Yoshihiko, Kikuchi Satoru, Shigeyasu Kunitoshi, Tazawa Hiroshi, Kagawa Shunsuke, Urata Yasuo, Fujiwara Toshiyoshi

СтатьяПеревод в очереди

Аннотация

The gut microbiota plays an essential role in regulating host immunity, and its metabolites such as butyrate exert immunomodulatory effects by acting as histone deacetylase inhibitors. Oncolytic virotherapy has emerged as a promising approach for cancer treatment, and we have developed OBP-702, a telomerase-specific oncolytic adenovirus that expresses p53 and elicits strong systemic antitumor responses. In this study, the potential synergy between butyrate and OBP-702 was investigated in colorectal cancer models. Using human and murine colorectal carcinoma cell lines, butyrate was found to directly enhance the infectivity of OBP-702 by upregulating CAR and integrins, thereby promoting apoptosis and autophagy in tumor cells. In addition, butyrate indirectly boosted systemic antitumor immunity by upregulating MHC-I expression through activation of the cGAS-STING pathway and enhancing CD8 + T cell recruitment via CXCL10 secretion. These findings were supported by in vivo experiments using CT26 subcutaneous, bilateral, and orthotopic tumor models, in which the combination of oral butyrate and intratumoral OBP-702 administration produced synergistic antitumor effects. These results highlight the therapeutic potential of integrating gut microbial metabolites with oncolytic virotherapy as a novel immunotherapeutic strategy for colorectal cancer.

Для цитирования: Sakamoto Masaki, Kuroda Shinji, Katayama Tetsuya, Mikane Yu, Hanzawa Shunya, Kadowaki Daisuke, Yoshida Yusuke, Hamada Yuki, Sugimoto Ryoma, Yagi Chiaki, Hashimoto Masashi, Kanaya Nobuhiko, Kakiuchi Yoshihiko, Kikuchi Satoru, Shigeyasu Kunitoshi, Tazawa Hiroshi, Kagawa Shunsuke, Urata Yasuo, Fujiwara Toshiyoshi. Gut microbial metabolite butyrate boosts p53-expressing telomerase-specific oncolytic adenovirus efficacy by enhancing infectivity and activating MHC-I/cGAS-STING.. Cancer immunology, immunotherapy : CII. 2025. DOI: 10.1007/s00262-025-04252-4.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.